Cover Image
市場調查報告書

腳關節重建:醫療設備的開發平台評估

Ankle Replacement - Medical Devices Pipeline Assessment, 2017

出版商 GlobalData 商品編碼 357840
出版日期 內容資訊 英文 62 Pages
訂單完成後即時交付
價格
Back to Top
腳關節重建:醫療設備的開發平台評估 Ankle Replacement - Medical Devices Pipeline Assessment, 2017
出版日期: 2017年03月16日 內容資訊: 英文 62 Pages
簡介

本報告提供腳關節重建相關之開發中產品調查,提供您各開發階段趨勢和產品的主要開發企業,現在進行中的臨床實驗,產業的近幾年趨勢等資訊。

第1章 目錄

第2章 簡介

  • 腳關節重建概要

第3章 開發中的產品

  • 腳關節重建 - 開發中產品:各開發階段
  • 腳關節重建 - 開發中產品:各市場區隔
  • 腳關節重建 - 開發中產品:各地區 (國家)
  • 腳關節重建 - 開發中產品:各法規途徑
  • 腳關節重建 - 開發中產品:各核准時期 (估計)

第4章 腳關節重建 - 正在開發的開發中產品:各企業

  • 腳關節重建企業 - 開發中產品:各開發階段
  • 腳關節重建 - 開發中產品:各開發階段

第5章 腳關節重建 開發企業與產品概要

  • Exactech, Inc.
  • Implants International Limited
  • Integra LifeSciences Holdings Corporation
  • NDSU Research Foundation
  • Wright Medical Group N.V.
  • Zimmer Biomet Holdings, Inc.

第6章 腳關節重建 - 近幾年趨勢

第7章 附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDME0313EPD

GlobalData's Medical Devices sector report, "Ankle Replacement - Medical Devices Pipeline Assessment, 2017" provides an overview of Ankle Replacement currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and the number of trials for the key Ankle Replacement pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Ankle Replacement under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Ankle Replacement and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Ankle Replacement under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents

1 Table of Contents 2

  • 1.1 List of Tables 4
  • 1.2 List of Figures 4

2 Introduction 5

  • 2.1 Ankle Replacement Overview 5

3 Products under Development 6

  • 3.1 Ankle Replacement - Pipeline Products by Stage of Development 6
  • 3.2 Ankle Replacement - Pipeline Products by Segment 7
  • 3.3 Ankle Replacement - Pipeline Products by Territory 8
  • 3.4 Ankle Replacement - Pipeline Products by Regulatory Path 9
  • 3.5 Ankle Replacement - Pipeline Products by Estimated Approval Date 10

4 Ankle Replacement - Pipeline Products under Development by Companies 11

  • 4.1 Ankle Replacement Companies - Pipeline Products by Stage of Development 11
  • 4.2 Ankle Replacement - Pipeline Products by Stage of Development 12

5 Ankle Replacement Companies and Product Overview 13

  • 5.1 Integra LifeSciences Holdings Corp Company Overview 13
    • 5.1.1 Integra LifeSciences Holdings Corp Pipeline Products & Ongoing Clinical Trials Overview 13
  • 5.2 NDSU Research Foundation Company Overview 15
    • 5.2.1 NDSU Research Foundation Pipeline Products & Ongoing Clinical Trials Overview 15
  • 5.3 Wright Medical Group NV Company Overview 16
    • 5.3.1 Wright Medical Group NV Pipeline Products & Ongoing Clinical Trials Overview 16
  • 5.4 Zimmer Biomet Holdings Inc Company Overview 18
    • 5.4.1 Zimmer Biomet Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview 18

6 Ankle Replacement- Recent Developments 19

  • 6.1 Feb 27, 2017: Orthofix International Reports Fourth Quarter and Fiscal 2016 Financial Results 19
  • 6.2 Feb 23, 2017: Integra LifeSciences Reports Fourth Quarter and Full-Year 2016 Financial Results and Updates 2017 Full-Year Guidance 20
  • 6.3 Feb 21, 2017: Wright Medical Group Reports 2016 Fourth Quarter and Full-Year Financial Results and Provides 2017 Guidance 21
  • 6.4 Feb 21, 2017: Exactech 2016 Revenue Up 7% to $257.6 Million, Q4'16 Revenue Increased 6% to $66.2 Million 23
  • 6.5 Jan 31, 2017: Zimmer Biomet Reports Fourth Quarter and Full-Year 2016 Financial Results 25
  • 6.6 Jan 18, 2017: Orthofix Announces Resolution of SEC Investigations 26
  • 6.7 Jan 17, 2017: Zimmer Biomet Announces Americas Leadership Transition 26
  • 6.8 Jan 17, 2017: Corin welcomes Elvio Gramignano 27
  • 6.9 Jan 12, 2017: Zimmer Biomet Announces Resolution with DOJ and SEC Regarding Previously Disclosed Legacy Biomet FCPA Matters 27
  • 6.10 Jan 10, 2017: Zimmer Biomet Announces Fourth Quarter and Full-Year 2016 Preliminary Sales Results 28
  • 6.11 Jan 10, 2017: Orthofix Announces Preliminary 2016 Fourth Quarter and Full Year Net Sales Results 29
  • 6.12 Dec 14, 2016: Zimmer Biomet Update on Product Supply Matters and Responsive Statement on Recently Completed FDA Inspection 29
  • 6.13 Dec 13, 2016: Orthofix Announces Appointment of Alex Lukianov to Board of Directors 30
  • 6.14 Dec 07, 2016: Arthrosurface names new executive chairman 30
  • 6.15 Dec 05, 2016: Integra LifeSciences announces management changes 31
  • 6.16 Dec 05, 2016: Integra LifeSciences Announces Key Executive Appointments 31
  • 6.17 Nov 02, 2016: Wright Medical Group Reports 2016 Third Quarter Financial Results and Updates 2016 Guidance 32
  • 6.18 Oct 31, 2016: Zimmer Biomet Reports Third Quarter 2016 Financial Results 34
  • 6.19 Oct 31, 2016: Exactech Q3 Revenue Up 7% to $59.9 Million. Net Income up 10% to $3.2 Million. Diluted EPS $0.22 vs. $0.20. 35
  • 6.20 Oct 31, 2016: Orthofix International Reports Third Quarter 2016 Financial Results 36
  • 6.21 Oct 27, 2016: Integra LifeSciences Reports Third Quarter 2016 Financial Results 38
  • 6.22 Oct 13, 2016: Exactech Breaks Ground in Foot and Ankle Market with Successful First Surgery 39
  • 6.23 Oct 10, 2016: Northgate Public Services secures five year contract extension with the National Joint Registry 39
  • 6.24 Sep 20, 2016: Integra LifeSciences Announces First Clinical Uses of Cadence Total Ankle System in Europe 40
  • 6.25 Aug 02, 2016: Wright Medical Group Reports 2016 Second Quarter Financial Results and Increases 2016 Guidance 41
  • 6.26 Aug 01, 2016: Exactech Q2 Revenue Up 8% to $66.1 Million; Net Income up 20% to $4.4 Million; Diluted EPS $0.31 vs. $0.26 44
  • 6.27 Aug 01, 2016: Orthofix International Reports Second Quarter 2016 Financial Results 45
  • 6.28 Jul 28, 2016: Zimmer Biomet Reports Second Quarter 2016 Financial Results 46
  • 6.29 Jul 28, 2016: Integra LifeSciences Reports Second Quarter 2016 Financial Results 47
  • 6.30 Jul 20, 2016: Wright Medical Group Highlights Recent Innovations at the American Orthopaedic Foot and Ankle Society 2016 Annual Meeting 49
  • 6.31 Jul 20, 2016: Wright Medical Group Highlights Recent Innovations at the American Orthopaedic Foot and Ankle Society (AOFAS) 2016 Annual Meeting 50
  • 6.32 Jun 13, 2016: Zimmer Biomet Raises USD1.28 Billion in Public Offering of Shares 51
  • 6.33 Jun 07, 2016: Zimmer Biomet Raises USD532 Million in Public Offering of 2.42% Notes Due 2026 51
  • 6.34 Jun 07, 2016: Zimmer Biomet Raises USD532 Million in Public Offering of 1.4% Notes Due 2022 51
  • 6.35 May 23, 2016: Wright Medical to Raise Funds in Public Offering of Shares 52
  • 6.36 May 13, 2016: Wright Medical to Raise USD395 Million in Private Placement of 2.25% Notes Due 2021 52
  • 6.37 May 04, 2016: Wright Medical Group Reports 2016 First Quarter Financial Results and Increases 2016 Guidance 52
  • 6.38 Apr 28, 2016: Orthofix International Reports First Quarter 2016 Financial Results 54
  • 6.39 Apr 27, 2016: Integra LifeSciences Reports First Quarter 2016 Financial Results 55
  • 6.40 Apr 26, 2016: Integra LifeSciences Announces Initial Clinical Use of the Cadence Total Ankle System in the United States 56
  • 6.41 Apr 21, 2016: Exactech Receives FDA 510(k) Clearance for Vantage Total Ankle 57
  • 6.42 Apr 04, 2016: Arthrex Recognized by American Heart Association as a Platinum Fit-Friendly Worksite 57

7 Appendix 59

  • 7.1 Methodology 59
  • 7.2 About GlobalData 62
  • 7.3 Contact Us 62
  • 7.4 Disclaimer 62

List of Tables

1.1 List of Tables

  • Table 1: Ankle Replacement - Pipeline Products by Stage of Development 6
  • Table 2: Ankle Replacement - Pipeline Products by Segment 7
  • Table 3: Ankle Replacement - Pipeline Products by Territory 8
  • Table 4: Ankle Replacement - Pipeline Products by Regulatory Path 9
  • Table 5: Ankle Replacement - Pipeline Products by Estimated Approval Date 10
  • Table 6: Ankle Replacement Companies - Pipeline Products by Stage of Development 11
  • Table 7: Ankle Replacement - Pipeline Products by Stage of Development 12
  • Table 8: Integra LifeSciences Holdings Corp Pipeline Products & Ongoing Clinical Trials Overview 13
  • Table 9: 2-Piece Total Ankle Replacement System - Product Status 13
  • Table 10: 2-Piece Total Ankle Replacement System - Product Description 14
  • Table 11: NDSU Research Foundation Pipeline Products & Ongoing Clinical Trials Overview 15
  • Table 12: Total Ankle Replacement Device - Product Status 15
  • Table 13: Total Ankle Replacement Device - Product Description 15
  • Table 14: Wright Medical Group NV Pipeline Products & Ongoing Clinical Trials Overview 16
  • Table 15: INVISION Revision Ankle System - Product Status 16
  • Table 16: INVISION Revision Ankle System - Product Description 16
  • Table 17: ORTHOLOC 3Di Ankle Fracture Low Profile System - Product Status 17
  • Table 18: ORTHOLOC 3Di Ankle Fracture Low Profile System - Product Description 17
  • Table 19: Zimmer Biomet Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview 18
  • Table 20: Two-part Semiconstrained Ankle Prosthesis Device - Product Status 18
  • Table 21: Two-part Semiconstrained Ankle Prosthesis Device - Product Description 18
  • Table 22: Glossary 61

List of Figures

1.2 List of Figures

  • Figure 1: Ankle Replacement - Pipeline Products by Stage of Development 6
  • Figure 2: Ankle Replacement - Pipeline Products by Segment 7
  • Figure 3: Ankle Replacement - Pipeline Products by Territory 8
  • Figure 4: Ankle Replacement - Pipeline Products by Regulatory Path 9
  • Figure 5: Ankle Replacement - Pipeline Products by Estimated Approval Date 10
Back to Top